Trends in chlamydia positivity over time among women in melbourne Australia, 2003 to 2007

Sexually Transmitted Diseases

Volumn 36, Issue 12, 2009, Pages 763-767

  O'Rourke, K M ^a,b   Fairley, Christopher K ^a,c   Samaranayake, Anil ^a,c   Collignon, Peter ^d   Hocking, Jane S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Department of Human Services ^*  (Australia)

^c MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

^d CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; COTRIMOXAZOLE; MACROLIDE; TETRACYCLINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CHILD; CHLAMYDIASIS; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PREVALENCE; RISK FACTOR; SCHOOL CHILD; TREND STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; CHILD; CHLAMYDIA; CHLAMYDIA INFECTIONS; FEMALE; HUMANS; MIDDLE AGED; PREVALENCE; VICTORIA; WOMEN'S HEALTH; YOUNG ADULT;

EID: 73949139563     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181b12765     Document Type: Article

References (26)

1. Number of notifications of Chlamydial infections, Australia, 2008 by age group and sex, [cited February 25, 2009]. Available at: http://www1.health.gov. au/cda/Source/Rpt-5.cfm.
2. Peipert JF. Genital Chlamydial Infections. N Engl J Med 2003 349 2424-2430.
3. Medicare Australia. Medical Benefits Schedule Item Statistics 69316, 69317, 69319, [cited May 5, 2009]. Available at: www. medicareaustralia.gov.au.
4. Hocking J, Fairley CK, Counahan M, et al. The pattern of notification and testing for genital Chlamydia trachomatis infection in Victoria, 1998-2000: An ecological analysis. Aust N Z J Public Health 2003; 27:405-408.
5. Smittskyddsinstitutet (Swedish Institute for Infectious Disease Control). Epidemiologisk arsrapport 2005. Solna: Smittskyddsin-stitutet (Swedish Institute for Infectious Disease Control), 2006.
6. Centres for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2004 Supplement. Chlamydia Prevalence Monitoring Project Annual Report 2004. Atlanta, GA: Department of Health and Human Services, Centres for Disease Control and Prevention, 2005.
7. Klovstad H, Aavitsland P. Chlamydia trachomatis infections in Norway, 1986 to 2006, surveillance data. Sex Transm Dis 2009; 36:17-21.
8. Statens Serum Institut. Epi-News: National Surveillance of Communicable Diseases. Copenhagen: Statens Serum Institut, 2005.
9. Goetz H, Lindbaeck J, Ripa T, et al. Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods? Scand J Infect Dis 2002; 34:28-34.
10. Hocking JS, Walker J, Regan D, et al. Chlamydia screening-Australia must strive to achieve what others have not. Med J Aust 2008; 188:106-108.
11. Fine D, Dicker L, Mosure D, et al. Increasing chlamydia posi-tivity in women screened in family planning clinics: Do we know why? Sex Transm Dis 2008; 35:47-52
12. Venereology Society of Victoria, Australasian Chapter of Sexual Health Physicians. National Management Guidelines for Sexually Transmissible Infections. Carlton, Australia: Venereology Society of Victoria Incorporated, 2002.
13. Ginige S, Chen MY, Hocking J, et al. Antibiotic consumption and chlamydia prevalence in international studies. Sex Health 2006; 3:221-224.
14. National Prescribing Service. Antibiotic use in Australia, 2008. Available at: http://www.nps.org.au/.
15. Holmes KK, Sparling PF, Stamm WE, et al. Sexually Transmitted Diseases. 4th ed. New york, NY: Mc Grow Hill Inc, 2008:585-589.
16. Miller WC, Hoffman IF, Owen-O'Dowd J, et al. Selective screening for chlamydial infections: Which criteria to use? Am J Prev Med 2000; 18:115-122.
17. Hocking J, Fairley CK. Do the characteristics of sexual health centre clients predict chlamydia infection sufficiently strongly to allow selective screening? Sex Health 2005; 2:185-192.
18. StataCorp. Stata Statistical Software: Release 9.0. College Station, TX: Stata Corporation, 2005.
19. McNamee KM, Fairley CK, Hocking JS. Chlamydia testing and notification in Australia: More money, more tests. Sex Transm Infect 2008; 84:565-569.
20. Foxman B, Newman M, Percha B, et al. Measures of sexual partnerships: Lengths, gaps, overlaps, and sexually transmitted infection. Sex Transm Dis 2006; 33:209-214.
21. Hoover K, Tao G, Kent C. Low rates of both asymptomatic chlamydia screening and diagnostic testing of women in U.S. outpatient clinics. Obstet Gynecol 2008; 112:891-898.
22. Donovan B. Rising prevalence of genital Chlamydia trachomatis infection in heterosexual patients at the Sydney Sexual Health Centre, 1994-2000. Commun Dis Intell 2002; 26:51-55.
23. Currie M, Bowden F. An epidemic of infection, not just testing: Chlamydia prevalence estimates in the Australian Capital Territory 1998-2004. Aust N Z J Public Health 2006; 30:286.
24. Rissel C, Richters J, Grulich A, et al. Sex in Australia: First experiences of vaginal intercourse and oral sex among a representative sample of adults. Aust N Z J Public Health 2003; 27:131-137.
25. Chen MY, Rohrsheim R, Donovan B. The differing profiles of symptomatic and asymptomatic Chlamydia trachomatis-infected men in a clinical setting. Int J STD AIDS 2007; 18:384-388.
26. Chen MY, Fairley CK, De Guingand D, et al. Screening pregnant women for chlamydia: What are the predictors of infection? Sex Transm Infect 2009; 85:31-35.